Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 1/20 | 0.61 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.41 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PNP | P00491 | 1/20 | 0.38 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.36 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.36 |
| ▸ | XDH | P47989 | 2/20 | 0.36 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.35 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16146853 | 0.80 | PDPK1 (0.41) | CDK2PDPK1GDADPP4ALDH1A1 | |
| SCHEMBL533603 | 0.79 | PDPK1 (0.44) | CDK2PDPK1GDADPP4ALDH1A1 | |
| SCHEMBL532461 | 0.79 | CDK2 (0.66) | CDK2PDPK1GDADPP4ALDH1A1 | |
| SCHEMBL2997392 | 0.76 | DPP4 (0.61) | CDK2PDPK1GDADPP4ALDH1A1 | |
| SCHEMBL612211 | 0.76 | GDA (0.41) | CDK2PDPK1GDADPP4ALDH1A1 | |
| SCHEMBL29873925 | 0.76 | PDPK1 (0.66) | CDK2PDPK1GDADPP4PNP | |
| SCHEMBL497199 | 0.76 | PDPK1 (0.66) | CDK2PDPK1GDADPP4PNP | |
| SCHEMBL135690 | 0.76 | CDK2 (1.00) | CDK2PDPK1GDADPP4MAP3K5 | |
| SCHEMBL5935896 | 0.76 | CDK2 (0.61) | CDK2PDPK1GDADPP4CSNK2A1 | |
| SCHEMBL16146291 | 0.72 | CDK2 (0.45) | CDK2PDPK1GDADPP4XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7307167-B2 | Production method of 2,6-dihalopurine | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-12-11 | — | — | US | disclosed |
| EP-1490369-B1 | PRODUCTION METHOD OF 2,6-DIHALOPURINE | SUMITOMO CHEMICAL CO (JP) | 2007-11-14 | — | — | EP | disclosed |
| CN-1314685-C | Process for preparing 2, 6-dihalogenopurine | SUMITOMO CHEMICAL CO (JP) | 2007-05-09 | — | — | CN | disclosed |
| CN-1646532-A | Process for preparing 2, 6-dihalogenopurine | SUMITOMO CHEMICAL CO (JP) | 2005-07-27 | — | — | CN | disclosed |
| US-20050131229-A1 | Production method of 2,6-dihalopurine | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-06-16 | — | — | US | disclosed |
| EP-1490369-A1 | PRODUCTION METHOD OF 2,6-DIHALOPURINE | Sumitomo Chemical Company, Limited (JP) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084958-A1 | PRODUCTION METHOD OF 2,6-DIHALOPURINE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131229-A1 | Production method of 2,6-dihalopurine | TPMT, DHPS, DUS2 | CDK2 88/4885PDPK1 1702/4885GDA 126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.